Paul Daly graduated in Pharmacy from the University of Manchester UK and went on to complete a PhD in Pharmaceutical Technology at the University of Nottingham UK. In addition, he completed a Diploma in Management Studies at the Trent Nottingham University. First positions in the Pharma Industry included Parenterals Formulation Development at Welcome and Solid Dose Formulations at Astra Zeneca before moving into Technical Operations within AZ UK. He then went on to join Syntex / Roche US in the areas of Technology Transfer and Management of Pharmaceutical Drug Product Pilot Plants. At Johnson and Johnson he moved into Sr Quality roles before becoming VP of Tech Services focusing on the manufacture of highly potent compounds. Later he joined BMS as the SVP of Manufacturing Technology / Global Engineering and was responsible for the Design and Build of DP Parenteral facilities together with large scale Biologics DS facilities. After three years as the SVP of Americas Quality for TEVA, he has spent the last six years as the Corp VP and overall Head of Quality for Celgene, with a particular interest in the latest oncology immunotherapy developments and their associated commercial facility Design and Qualification.